Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPM1B | O75688 | 5/20 | 0.56 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.52 |
| ▸ | PPP1CC | P36873 | 1/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | GAA | P10253 | 1/20 | 0.45 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10083154 | 1.00 | PPM1B (0.56) | PPM1BKMT2AMEN1PTPN1PPP1CC | |
| SCHEMBL16788624 | 1.00 | PPM1B (0.56) | PPM1BKMT2AMEN1PTPN1PPP1CC | |
| SCHEMBL16790508 | 1.00 | PPM1B (0.56) | PPM1BKMT2AMEN1PTPN1PPP1CC | |
| SCHEMBL19388139 | 1.00 | PPM1B (0.56) | PPM1BKMT2AMEN1PTPN1PPP1CC | |
| SCHEMBL2002666 | 0.92 | PPM1B (0.44) | PPM1BKMT2AMEN1PTPN1PPP1CC | |
| SCHEMBL9696402 | 0.92 | PPM1B (0.44) | PPM1BKMT2AMEN1PTPN1PPP1CC | |
| SCHEMBL2005428 | 0.92 | PPM1B (0.44) | PPM1BKMT2AMEN1PTPN1PPP1CC | |
| SCHEMBL26844637 | 0.84 | PPM1B (0.40) | PPM1BKMT2AMEN1PTPN1PPP1CC | |
| SCHEMBL3818435 | 0.83 | PPM1B (0.50) | PPM1BKMT2AMEN1ALDH1A1KDM4E | |
| SCHEMBL238046 | 0.83 | PPM1B (0.50) | PPM1BKMT2AMEN1ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230341777-A1 | RESIST UNDERLAYER FILM-FORMING COMPOSITION CONTAINING TERMINAL-BLOCKED REACTION PRODUCT | NISSAN CHEMICAL CORPORATION (JP) | 2023-10-26 | — | — | US | disclosed |
| US-20230296984-A1 | EUV RESIST UNDERLAYER FILM-FORMING COMPOSITION | NISSAN CHEMICAL CORPORATION (JP) | 2023-09-21 | — | — | US | disclosed |
| US-20230259028-A1 | RESIST UNDERLAYER FILM-FORMING COMPOSITION CONTAINING REACTION PRODUCT OF HYDANTOIN COMPOUNDS | NISSAN CHEMICAL CORPORATION (JP) | 2023-08-17 | — | — | US | disclosed |
| US-20230259028-A1 | RESIST UNDERLAYER FILM-FORMING COMPOSITION CONTAINING REACTION PRODUCT OF HYDANTOIN COMPOUNDS | NISSAN CHEMICAL CORPORATION (JP) | 2023-08-17 | — | — | US | disclosed |
| US-20180127520-A1 | METHOD FOR PRODUCING RING-OPENING METATHESIS POLYMER HYDRIDE, AND RESIN COMPOSITION | ZEON CORPORATION (JP) | 2018-05-10 | — | — | US | disclosed |
| US-9850325-B2 | Method for producing ring-opening metathesis polymer hydride, and resin composition | ZEON CORPORATION (JP) | 2017-12-26 | — | — | US | disclosed |
| US-9770511-B2 | Protein transduction domains mimics | UNIVERSITY OF MASSACHUSETTS (US) | 2017-09-26 | — | — | US | disclosed |
| US-20160324970-A1 | PROTEIN TRANSDUCTION DOMAINS MIMICS | UNIV MASSACHUSETTS (US) | 2016-11-10 | — | — | US | disclosed |
| EP-2270063-B1 | PROCESS FOR PRODUCING HYDROGENATED PRODUCT OF CYCLIC OLEFIN POLYMER PREPARED THROUGH RING-OPENING POLYMERIZATION | ZEON CORP (JP) | 2016-03-23 | — | — | EP | disclosed |
| US-20150051353-A1 | METHOD FOR PRODUCING RING-OPENING METATHESIS POLYMER HYDRIDE, AND RESIN COMPOSITION | ZEON CORPORATION (JP) | 2015-02-19 | — | — | US | disclosed |
| US-20050014916-A1 | Ruthenium complexes, process for preparation thereof, and processes for producing open-ring polymer of cycloolefins and hydrogenation products thereof by using the complex as catalyst | ZEON CORPORATION (JP) | 2005-01-20 | — | — | US | disclosed |
| EP-1048350-B1 | Polymeric homogeneous catalysts | DEGUSSA (DE) | 2004-06-02 | — | — | EP | disclosed |
| EP-0776924-B1 | Polyimide composition and method for producing prepreg and paint using the same | MITSUBISHI HEAVY IND LTD (JP) | 2003-09-24 | — | — | EP | disclosed |
| US-20030050406-A1 | Process for producing hydrogenated product of cyclic olefin polymer prepared through ring-opening polymerization | ZEON CORPORATION | 2003-03-13 | — | — | US | disclosed |
| US-6486264-B1 | Process for producing hydrogenated ring-opening polymerization polymer of cycloolefin | ZEON CORPORATION (JP) | 2002-11-26 | — | — | US | disclosed |
| US-6403522-B1 | CONTAINING AN UNSATURATED POLYMER BACKBONE GENERATED BY RING OPENING METATHESIS POLYMERIZATION; MORE RIGID; REACTING A RUTHENIUM OR MOLYBDENUM CARBENE CATALYST WITH A BICYCLIC OLEFIN | DEGUSSA AG (DE) | 2002-06-11 | — | — | US | disclosed |
| EP-1197509-A1 | PROCESS FOR PRODUCING HYDROGENATED RING-OPENING POLYMERIZATION POLYMER OF CYCLOOLEFIN | Nippon Zeon Co., Ltd. (JP) | 2002-04-17 | — | — | EP | disclosed |
| EP-1048350-A1 | Polymeric homogeneous catalysts | Degussa-Hüls Aktiengesellschaft (DE) | 2000-11-02 | — | — | EP | disclosed |
| US-5914385-A | Polyimide resin composition and method for producing prepreg and paint and method for curing resin using the same | MITSUBISHI JUKOGYO KABUSHIKI KAISHA (JP) | 1999-06-22 | — | — | US | disclosed |
| EP-0776924-A2 | Polyimide composition and method for producing prepreg and paint using the same | MITSUBISHI JUKOGYO KABUSHIKI KAISHA (JP) | 1997-06-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050014916-A1 | Ruthenium complexes, process for preparation thereof, and processes for producing open-ring polymer of cycloolefins and hydrogenation products thereof by using the complex as catalyst | POR, CAD, HRH1 | PPM1B 4615/4885KMT2A 1706/4885MEN1 2549/4885 |
| US-20160324970-A1 | PROTEIN TRANSDUCTION DOMAINS MIMICS | PHAX, GHITM, MAVS | PPM1B 3467/4885KMT2A 4710/4885MEN1 947/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.